Quantessence Capital’s Alkermes ALKS Stock Holding History

Quantessence Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,300	Closed	-$373K	–	193
2025 Q1	$373K	Sell	11,300 -1,177	-9%	-$38.4K	0.09%	213
2024 Q4	$359K	Buy	+12,477	New	+$359K	0.15%	153

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Quantessence Capital's ALKS Position: Q2 2025 in Review

Quantessence Capital sold out of Alkermes (ALKS) in Q2 2025, closing a stake of 11,300 shares — an estimated $373K sold.

Quantessence Capital first reported a position in ALKS in Q4 2024 and held it in 2 quarters. The position peaked at $373K in Q1 2025. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

Quantessence Capital reported no remaining Alkermes position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 11,300 Alkermes shares in Q2 2025, an estimated $373K.
Quantessence Capital first reported a position in Alkermes in Q4 2024 and held it in 2 quarters.
Quantessence Capital's Alkermes position peaked at $373K in Q1 2025.
353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.